ARCHIVES

ODAC Member Critical Of Amgen For Price Incentives.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

Professional Societies: AACR Presents Awards At Annual Meeting

April 18, 1997

In Brief: Krakoff moves To Scotland; Salmon Wins Waldenstrom Award; ONS endorses Reform

November 5, 1993

FDA Approves Two Oral Drugs For Metastatic Melanoma

June 28, 2013

CT Scanning Advocates Propose Pooling Data From Randomized Trials, I-ELCAP.

November 16, 2007

FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds

December 26, 2003

Cancer Incidence Rates For Recent Years Too Optimistic, NCI Researchers Find

October 25, 2002